A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer responseArticle Published on 2022-12-012022-11-15 Journal: Analytical biochemistry [Category] COVID19(2023년), SARS, 진단, [키워드] Antibody titer chemiluminescent immunoassay CLIA CMIA Convalescent plasma therapy Coronavirus disease 2019 COVID-19 Efficacy effort ELISA human donor identify immune response Immune titer immunoassay Lateral LFIA pandemic plaque PRNT reactive SARS-CoV-2 serological serological test Serologist Serologist method serology test Test Vaccine vaccine. Vaccines [DOI] 10.1016/j.ab.2022.114902 PMC 바로가기
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective studyArticle Published on 2022-10-312022-11-15 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 95% CI Accuracy acute respiratory syndrome Analysis antibodies antibody Antibody detection assessments Blood capillary blood chemiluminescent immunoassay CLIA coronavirus coronavirus disease COVID-19 COVID-19 disease cut off cut-off Diagnosis diagnosis of COVID-19 diagnostic Efficacy ELISA evaluate facilitate gold standard identify IgM and IgG immunochromatographic assay information intensity Italy Laboratory Lateral lateral flow lateral flow immunoassay Lateral flow test measure NAAT Non-invasive nucleic acid amplification Patient patients performed POC positive Prospective Study provided Quantitative Rapid Rapid diagnostic test RDT SARS-CoV-2 SARS-CoV-2 antibody semi-quantitative sensitivity serological test serology Serology. Severity of disease specificity symptom onset Test the timing venous whole sample [DOI] 10.1186/s12879-022-07786-5 PMC 바로가기
Concordance of SARS-CoV-2 Antibody Results during a Period of Low PrevalenceArticle Published on 2022-10-262022-11-15 Journal: mSphere [Category] COVID19(2023년), SARS, 진단, [키워드] 95% confidence interval Abbott acute respiratory syndrome Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG Antigen antigens Architect assays CDC collected combinations Concentration Concordance contributed coronavirus coronavirus disease COVID-19 Elecsy ELISA enzyme-linked immunosorbent evaluate False positivity first test Frequency IgG IgG antibodies immunoassay immunoassays Immunoglobulin individual investigated low prevalence nucleocapsid nucleocapsid protein pandemic participant Participants performed Period positive positive result Prevalence produced proportion quantified Research Result Roche SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 IgG antibody sequential test sera serological test seropositive specimen Spike protein spike protein. subset Support target tested the SARS-CoV-2 The United States Vaccine vaccine availability [DOI] 10.1128/msphere.00257-22 PMC 바로가기
SARS-CoV-2 Transmission Prevention Model Application in a Large Retail Company Before the Vaccine IntroductionArticle Published on 2022-10-142022-11-15 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 치료기술, [키워드] activities activity antigenic application body temperature company Contagion control group country COVID-19 detect distribution early stage Food industry Health hospitals Italian legislation Italy lockdown measure Measures Model National pandemic pandemic status pharmacies positive prevention protocol provided public health measure reduce reduction restrict SARS- CoV-2 SARS-CoV-2 SARS-CoV-2 prevention serological test significantly Spread state subject Swab Telemedicine Transmission transmission prevention model vaccination virus was selected WHO Workplace. [DOI] 10.3389/fpubh.2022.908690 PMC 바로가기
Optimizing the implementation of a participant-collected, mail-based SARS-CoV-2 serological survey in university-affiliated populations: lessons learned and practical guidanceArticle Published on 2022-10-122022-11-15 Journal: BMC Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] antibody applicability approach Blood change distribution driven by enrolled Epidemiologic methods feasibility Field epidemiology Future Guidance highlight identify implementation Laboratory Massachusetts Pathogens pre-symptomatic Prevalence recruitment Research SARS-CoV-2 SARS-CoV-2 antibody serological survey serological test serology Serosurveys. Spread stratified Study design Study participants subclinical infection symptomatic individual USA utility virus [DOI] 10.1186/s12889-022-14234-1 PMC 바로가기
Post-Acute COVID-19 syndrome (PACS) right atrioventricular and vena cava thrombus on top of a myxoma. A Case reportArticle Published on 2022-10-082022-11-15 Journal: Journal of Cardiothoracic Surgery [Category] COVID19(2023년), SARS, 진단, [키워드] Admission antibody cardiac cardiac mass cardiac thrombus cardiac tumor case report. coronavirus disease COVID-19 female hepatomegaly hidden histopathological IgG and IgM Mild occur positive Post-acute COVID-19 Syndrome (PACS) right Right atrial myxoma SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2. serological test syndrome Thrombus thrombus formation tricuspid vena [DOI] 10.1186/s13019-022-01998-1 PMC 바로가기
External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021Article Published on 2022-10-012022-11-15 Journal: Eurosurveillance [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibodies characterisation collected composed country COVID-19 Critical detect Diagnosis diagnostics eight epidemiological EQA Europe European evaluate External human SARS-CoV-2 human serum immune response Immunoglobulin indicated involved Laboratory mitigate natural infection neutralising antibody participant performed provided public health measures robust SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antibody responses SARS-COV-2 infection SARS-CoV-2 pandemic SARS-CoV-2 transmission Sensitivity and specificity serological serological test serology Serology. Support the vaccine Vaccine [DOI] 10.2807/1560-7917.ES.2022.27.42.2101057 PMC 바로가기
Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted ProteomicsArticle Published on 2022-09-272022-11-15 Journal: Analytical Chemistry [Category] SARS, 유전자 메커니즘, 진단, 치료기술, 치료제, [키워드] anti-RBD anti-SARS-CoV-2 antibody approach Combination convalescent convalescent plasma COVID-19 cross-reactivity current Cutoff detect development diagnostic Diseases domain elevated facilitate highest human immunoglobulin IgA IgA2 IGD IgE IgG IgG1 IgG2 IgG3 IgG4 IgM immune response immunoassay Immunoglobulin include isotype lack limit of detection limitation offer plasma Protein proteomic proteomics quantification Saliva SARS-CoV-2 serological Serological assay serological test serum significantly Simultaneous Standardization suggested [DOI] 10.1021/acs.analchem.2c01325 PMC 바로가기
Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP “PERFECT-study” protocol (RIA2020EF-3000)Article Published on 2022-09-212022-11-15 Journal: PLoS ONE [Category] SARS, 변종, 치료기술, [키워드] affecting Amplicon assays Biorepository Care Clinical diagnosis Clinicians collected conducted confirmed case contribute COVID-19 COVID-19 infection creating diagnosing Diagnosis effective effort ELISA ENhance Epidemiology evaluated Evidence facilitate Fatality rate Follow-up Genetic identify IMPROVE individual individuals management measure molecular Molecular assay molecular assays PCR performed platform point-of-care positive protocol real-time qPCR risk SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV2 sera Serological assay serological test Serological testing specificity specimen strain Swab transfer translate Treatment well [DOI] 10.1371/journal.pone.0273818 PMC 바로가기
Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic reviewArticle Published on 2022-09-202022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료기술, [키워드] 95% CI Ad26 analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 vaccination antibodies antibody Antibody detection Antibody titer applied assays AstraZeneca convalescent individual correlation COVID-19 COVID-19 vaccines eligible ELISA assay evaluate flow cytometry highlight IgA IgG Immunity immunoassay Immunoglobulin immunological increasingly infected individuals janssen Johnson & Johnson lack moderate mRNA-based mucosal Neutralizing nine quantification reached reported Saliva Saliva. salivary SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 detection selected serological test serum serum/plasma systematic review vaccinated individual vaccination Vaccination strategy Vaccine Web of Science [DOI] 10.3389/fimmu.2022.1006040 PMC 바로가기